ENT-03

N/A

Report date: 2023/06/13 09:14:51
NME

Base Information

Drug NameENT-03
Drug Alias NameENT-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Alzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnterin Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetabolics Pharma IncEnterin Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Alzheimer Disease
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A